Tempus AI is facing a class action lawsuit for violating securities laws. Investors who purchased the company's securities between August 6, 2024, and May 27, 2025, may be eligible for compensation. The lawsuit alleges violations of §§10(b) and 20(a) of the Securities Exchange Act of 1934 and Rule 10b-5. Investors are encouraged to contact the Schall Law Firm by August 12, 2025, to discuss their rights.
Tempus AI, Inc. (NASDAQ: TEM) is facing a class action lawsuit alleging violations of federal securities laws. The lawsuit, filed by investors, seeks to recover damages for alleged misrepresentations and omissions made by the company during a specific period. Investors who purchased Tempus securities between August 6, 2024, and May 27, 2025, may be eligible to participate in the lawsuit.
The complaint, filed by law firms Bronstein, Gewirtz & Grossman, LLC [1] and The Schall Law Firm [2], alleges that Tempus made false and misleading statements regarding the company's business operations, financial commitments, and joint ventures. Key allegations include:
1. Inflated value of contract agreements with related parties and self-funded deals.
2. Risks associated with the joint venture with SoftBank, which appeared to involve "round-tripping" capital.
3. Aggressive and potentially unethical billing practices of Tempus-acquired Ambry.
4. Reduced financial commitments from AstraZeneca through a questionable "pass-through payment" agreement.
5. Materially false and misleading statements about the company's business prospects.
The price of Tempus common stock fell significantly following the revelation of these issues, dropping by $12.67 per share or 19.23% from $65.87 on May 27, 2025, to $53.20 on May 28, 2025 [1].
Investors are encouraged to contact the Schall Law Firm by August 12, 2025, to discuss their rights. The firm, which specializes in securities class action lawsuits and shareholder rights litigation, is currently accepting inquiries from investors who may have suffered losses due to Tempus' alleged securities violations.
For more information, investors can visit the Schall Law Firm's website at www.schallfirm.com or contact Brian Schall, Esq., at 310-301-3335 [2].
References:
[1] https://www.globenewswire.com/news-release/2025/08/08/3130351/9788/en/TEM-INVESTOR-ALERT-Bronstein-Gewirtz-Grossman-LLC-Announces-that-Tempus-AI-Inc-Investors-with-Substantial-Losses-Have-Opportunity-to-Lead-Class-Action-Lawsuit.html
[2] https://www.prnewswire.com/news-releases/tem-investors-have-opportunity-to-lead-tempus-ai-inc-securities-fraud-lawsuit-with-the-schall-law-firm-302526160.html
Comments
No comments yet